Aerospace

Engineered semiconductor materials for imaging & power generation
Engineered semiconductor materials for imaging & power generation

Imaging and sensing

Specialty semiconductor materials for medical imaging and diagnosis
Specialty semiconductor materials for medical imaging and diagnosis

Industrial materials

Specialty Alloys for Industrial Applications
Specialty Alloys for Industrial Applications

Health and pharmaceutical

Active pharmaceutical & dietary precursors for human & animal health
Active pharmaceutical & dietary precursors for human & animal health

Catalytic and Extractive

Catalytic and Extractive Materials for oil, gas and mining industries
Catalytic and Extractive Materials for oil, gas and mining industries

Renewable energy

Semiconductor materials for renewable power generation
Semiconductor materials for renewable power generation

Recycling and refining

Global recycling & refining assets & capabilities
Global recycling & refining assets & capabilities

Who we are

5N Plus is a leading global producer of engineered materials and specialty chemicals with integrated recycling and refining assets to manage the sustainability of its business model. The Company is headquartered in Montreal, Québec, Canada and operates R&D, manufacturing and commercial centers in several locations in Europe, the Americas and Asia. 5N Plus deploys a range of proprietary and proven technologies to manufacture products which are used as enabling precursors by its customers in a number of advanced electronics, optoelectronics, pharmaceutical, health, renewable energy and industrial applications. Many of the materials produced by 5N Plus are critical for the functionality and performance of the products and systems produced by its customers, many of whom are leaders within their industry.

5N21 Strategic Plan

Updated as of 04-2019
Download

Brochure

Unlocking Opportunities
Download

News

5N Plus Reports Strong Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2020

Montreal - February 23, 2021 5N Plus today reported financial results for the fourth quarter and fiscal year ended December 31, 2020.

5N Plus to Release Fourth Quarter Fiscal 2020 Results on February 23, 2021
Montreal - February 16, 2021 ‐ 5N Plus will release its fourth quarter results after market hours on February 23, 2021 and will host a conference call on February 24, 2021 at 8:00 a.m. (EST) to discuss the results.

To join the conference toll free, please dial 1-888-664-6392, or 416-764-8659 in Toronto. The conference access code is 17301716.
5N Plus Acquires Stake in Microbion and Secures Drug Substance Manufacturing Rights
Montreal, Québec and Bozeman, Montana, January 12, 2021 –– 5N Plus Inc. and Microbion Corporation, a clinical-stage pharmaceutical company focused on the development of compounds for the treatment of resistant and difficult-to-treat infections, jointly announced today that the parties have entered into a strategic relationship for the development, manufacturing and commercial drug substance supply of Microbion’s new class of antibiotic and antibiofilm drugs.
More news
© Copyright 2021 5N Plus - All Rights Reserved | Web Design by Akro. | Privacy Policy